Circulating microRNA Biomarkers as Liquid Biopsy for Cancer Patients: Pros and Cons of Current Assays

Journal of Clinical Medicine
doi 10.3390/jcm4101890
Full Text
Abstract

Available in full text

Date
Authors
Publisher

MDPI AG

Related search

Large-Scale Circulating microRNA Profiling for the Liquid Biopsy of Prostate Cancer

Clinical Cancer Research
Cancer ResearchOncology
2019English

Potential of Circulating Biomarkers in Liquid Biopsy Diagnostics

BioTechniques
BiochemistryBiotechnologyGeneticsMolecular Biology
2018English

Current Dietary Lipids Recommendations: Pros and Cons

Journal of Nutrition and Health Sciences
2016English

Circulating microRNA-92a and microRNA-21 as Novel Minimally Invasive Biomarkers for Primary Breast Cancer

Journal of Cancer Research and Clinical Oncology
MedicineCancer ResearchOncology
2012English

Correction: Circulating microRNA Signature as Liquid-Biopsy to Monitor Lung Cancer in Low-Dose Computed Tomography Screening

Oncotarget
Oncology
2019English

Pros and Cons

La négociation collective dans le milieu universitaire
2005English

JCSE01.05 Biomarkers and Liquid Biopsy for Early Detection of Lung Cancer

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

P2.11-19 MicroRNAs as Liquid Biopsy Biomarkers for Early Detection in Lung Cancer.

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

The TAP Block in Obese Patients: Pros and Cons

Minerva Anestesiologica
AnesthesiologyPain Medicine
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy